Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07513441 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Mar 31, 2026 to May 26, 2026 · Study sites revised (4)v2 Show 2 more changesShow less
    • Start date changed from estimate of Mar 31, 2026 to May 26, 2026
    • Study sites revised (4)

    See this version in full on ClinicalTrials.gov ↗

  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in participants with Parkinson's disease.
Trial Details
NCT Number NCT07513441
Lead Sponsor H. Lundbeck A/S
Conditions Parkinson Disease
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov